Company UpdateChange in Directorate
HealthcarePharmaceuticals & BiotechnologyPharmaceuticals
Lasa Supergenerics Ltd
Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 23 filings·Updated 25 Aug 2026
Showing 10 of 23 filings.
25 Aug 20262 filings
Company UpdateCessation
Ganesh Potdar resigns as Whole-time Director of Lasa Supergenerics, effective 25 August 2026
Cessation details
- Ganesh Suresh Potdar, Whole-time Director, resigns effective 25 August 2026 due to personal commitments.
- Whole-time Director role vacated; no interim arrangements disclosed.
18 Jul 20261 filing
Company UpdateStructural Digital Database
SDD certificate for the quarter ended June 2026
29 May 20261 filing
Board MeetingOutcome of Board Meeting
Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting For Quarter Ended March 31 St 2026
Financial results
- Board approved unaudited standalone financial results for quarter ended March 31, 2026.
- Board also approved the statutory auditor's limited review report with modified opinion.
Audit qualifications
- Auditor qualified the results over unresolved fire-related asset impairment and intangible asset impairment.
- Fire at the factory on May 18, 2025 damaged property, inventories, and other assets.
- Auditor noted no impairment assessment for patents, goodwill, and software worth Rs. 1,667.05 lakhs.
Material regulatory and legal matters
- Auditor highlighted GST demand notices aggregating Rs. 3,810.93 lakhs, currently under appeal.
- Auditor noted pending GST reconciliation issues and unquantified impact on results or financial position.
- Revenue recognition on one customer invoice remains suspended under force majeure, with Rs. 10.56 lakhs retained as liability.
Other disclosures
- Board approved the Statement on Impact of Audit Qualifications for year ended March 31, 2026.
- The statement was reviewed by the Audit Committee and approved by the Board on May 29, 2026.
12 May 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate Reg 74 (5) of SEBI (DP) Regulations , 2018 as on 31st March 2026
16 Apr 20261 filing
Company UpdateGeneral
Declaration with respect to non- applicability of Large Entities
30 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window
Closure of trading window for the quarter and year ended March 31, 2026
15 Jan 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg 74 (5) of SEBI (DP) Regulations, 2018
2 Jan 20261 filing
OthersOutcome without intimation
Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today ....
15 Dec 20251 filing
Company UpdateAppointment of Company Secretary / Compliance Officer
We wish to inform you that Mrs. Mitti Jain is hereby appoitned as Company secretary and Compliance Officer of the Company
Showing 10 of 23 filings